Home
Contact Us
Site Map
Home
> Investor Relations
Investor Relations
News Releases
11/6/2008
King Pharmaceuticals Reports Third-Quarter 2008 Financial Results
10/21/2008
King Pharmaceuticals Announces Date for Release of Third-Quarter 2008 Financial Results
10/13/2008
Acura Pharmaceuticals and King Pharmaceuticals Announce Positive Top Line Results of Key Clinical Study Assessing Abuse Liability
10/13/2008
King Pharmaceuticals Extends Tender Offer
9/26/2008
King Pharmaceuticals Responds to Alpharma Inc.
read more »
Home
About Us
Products
Investors
Business Development
Careers
Community
Contact Us
Site Map
Legal
©2000-2008 King Pharmaceuticals,
®
Inc. All rights reserved.
About Us
Vision
Who We Are
Why Choose King?
Strategy
Fast Facts
Products
Avinza® CII
Skelaxin®
Thrombin-JMI®
Altace®
Sonata® CIV
Levoxyl®
Meridian Auto injector Products/EpiPen®
Alphabetic Listing of Products
NDC Listing of Products
Authorized Distributors of Record
Investors
News Releases
Annual Report
SEC Documents
SEC Section 16 Reports
Governance
Webcasts
Business Development
Careers
Job Search
Benefits
Culture and Diversity
Why Choose King?
Locations
Community
Community Investment Program
Medical Education Grants
